NR4A1 and breast cancer: Moreover, an in-vitro study showed a significant reduction in proliferation and decreased expression of cyclin B1 expression in hormone receptor-positive MCF-7 and triple-negative MDA-MB-231 breast cancer cell lines by SAB.